Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)

A. H. Awada; M. Zematis; S. Ochsenreither; R. L. Eefsen; D. Arnold; S. Cicenas; J. Yachnin; P. Pfeiffer; L. Paz-Ares; C. Jungels; R. Greil; L. Ostergaard Poulsen; E. Van Cutsem; I. Garcia Ribas; L. Thorsson; J. J. Collignon

doi:10.1016/j.annonc.2021.08.1060

Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)

A. H. Awada
, M. Zematis
, S. Ochsenreither
, R. L. Eefsen
, D. Arnold
, S. Cicenas
, J. Yachnin
, P. Pfeiffer
, L. Paz-Ares
, C. Jungels
, R. Greil
, L. Ostergaard Poulsen
, E. Van Cutsem
, I. Garcia Ribas
, L. Thorsson
, J. J. Collignon

KI, OUH, Forskningsenhed for Onkologi (Odense)

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Annals of Oncology
Vol/bind	32
Udgave nummer	Suppl. 5
Sider (fra-til)	S602-S603
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2021.08.1060
Status	Udgivet - 2021
Begivenhed	ESMO Congress 2021: An enhanced virtual experience - Virtuelt Varighed: 16. sep. 2021 → 21. sep. 2021 https://www.esmo.org/meetings/past-meetings/esmo-congress-2021

Konference

Konference	ESMO Congress 2021
Lokation	Virtuelt
Periode	16/09/2021 → 21/09/2021
Internetadresse	https://www.esmo.org/meetings/past-meetings/esmo-congress-2021

Dokumenter og links

10.1016/j.annonc.2021.08.1060

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Awada, A. H., Zematis, M., Ochsenreither, S., Eefsen, R. L., Arnold, D., Cicenas, S., Yachnin, J., Pfeiffer, P., Paz-Ares, L., Jungels, C., Greil, R., Poulsen, L. O., Van Cutsem, E., Ribas, I. G., Thorsson, L., & Collignon, J. J. (2021). Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC). Annals of Oncology, 32(Suppl. 5), S602-S603. https://doi.org/10.1016/j.annonc.2021.08.1060

@article{846e5c548ec74e04a21b31b452feec96,

title = "Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)",

author = "Awada, \{A. H.\} and M. Zematis and S. Ochsenreither and Eefsen, \{R. L.\} and D. Arnold and S. Cicenas and J. Yachnin and P. Pfeiffer and L. Paz-Ares and C. Jungels and R. Greil and Poulsen, \{L. Ostergaard\} and \{Van Cutsem\}, E. and Ribas, \{I. Garcia\} and L. Thorsson and Collignon, \{J. J.\}",

year = "2021",

doi = "10.1016/j.annonc.2021.08.1060",

language = "English",

volume = "32",

pages = "S602--S603",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 5",

note = "ESMO Congress 2021 ; Conference date: 16-09-2021 Through 21-09-2021",

url = "https://www.esmo.org/meetings/past-meetings/esmo-congress-2021",

}

Awada, AH, Zematis, M, Ochsenreither, S, Eefsen, RL, Arnold, D, Cicenas, S, Yachnin, J, Pfeiffer, P, Paz-Ares, L, Jungels, C, Greil, R, Poulsen, LO, Van Cutsem, E, Ribas, IG, Thorsson, L & Collignon, JJ 2021, 'Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)', Annals of Oncology, bind 32, nr. Suppl. 5, s. S602-S603. https://doi.org/10.1016/j.annonc.2021.08.1060

Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC). / Awada, A. H.; Zematis, M.; Ochsenreither, S. et al.
I: Annals of Oncology, Bind 32, Nr. Suppl. 5, 2021, s. S602-S603.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)

AU - Awada, A. H.

AU - Zematis, M.

AU - Ochsenreither, S.

AU - Eefsen, R. L.

AU - Arnold, D.

AU - Cicenas, S.

AU - Yachnin, J.

AU - Pfeiffer, P.

AU - Paz-Ares, L.

AU - Jungels, C.

AU - Greil, R.

AU - Poulsen, L. Ostergaard

AU - Van Cutsem, E.

AU - Ribas, I. Garcia

AU - Thorsson, L.

AU - Collignon, J. J.

PY - 2021

Y1 - 2021

U2 - 10.1016/j.annonc.2021.08.1060

DO - 10.1016/j.annonc.2021.08.1060

M3 - Conference abstract in journal

SN - 0923-7534

VL - 32

SP - S602-S603

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 5

T2 - ESMO Congress 2021

Y2 - 16 September 2021 through 21 September 2021

ER -